Is There More Selling for Pfizer? | Technical Analysis

The Pfizer Inc. stock (NYSE: PFE) traded in a consolidative manner the last couple of weeks, staying near the 34.60 barrier, marked as a support by the low of October 29th. Overall, the stock remains below the prior upside support line drawn from the low of March 23rd, and thus, we would consider the near-term outlook to be negative for now.

If eventually we see the price clearing the 34.60 hurdle, it could then travel towards the low of July 9th, at 33.10. That zone may provide an initial support, but if there is still no sufficient buying interest, its break may carry more bearish implications, perhaps paving the way towards the low of June 26th, at 31.60.

Shifting attention to our daily oscillators, we see that the RSI ticked up after it hit support at its 30 line, while the MACD, although below both its zero and trigger lines, shows signs of bottoming as well. Both indicators detect slowing downside speed and suggest that a small bounce may be in the works before the next leg south, perhaps for the rate to test the 36.10 territory as a resistance this time.

That said, in order to start examining the positive case again, we would like to see a strong rebound back above 37.80. Such a move would also take the stock price back above the upside line taken from the low of March 23rd, and may encourage advances towards the 39.55 level, marked by the inside swing low of December 3rd. Another break, above 39.55, may see scope for extensions towards the 41.40 barrier, marked by the highs of November 9th and December 2nd, the break of which could open the path towards the peak of December 9th, at 43.05.

Disclaimer:

The content we produce does not constitute investment advice or investment recommendation (should not be considered as such) and does not in any way constitute an invitation to acquire any financial instrument or product. The Group of Companies of JFD, its affiliates, agents, directors, officers or employees are not liable for any damages that may be caused by individual comments or statements by JFD analysts and assumes no liability with respect to the completeness and correctness of the content presented. The investor is solely responsible for the risk of his investment decisions. Accordingly, you should seek, if you consider appropriate, relevant independent professional advice on the investment considered. The analyses and comments presented do not include any consideration of your personal investment objectives, financial circumstances or needs. The content has not been prepared in accordance with the legal requirements for financial analyses and must therefore be viewed by the reader as marketing information. JFD prohibits the duplication or publication without explicit approval.

There are risks involved with trading of cash equities. Past performance is not indicative of future results. You should consider whether you can tolerate such losses before trading. Please read the full Risk Disclosure.

Copyright 2021 JFD Group Ltd.